Terry Vance is a director of Enanta Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ENANTA PHARMACEUTICALS INC
17 Mar 23
4
ENANTA PHARMACEUTICALS INC
6 Mar 23
4
ENANTA PHARMACEUTICALS INC
7 Mar 22
4
ENANTA PHARMACEUTICALS INC
4 Mar 21
4
ENANTA PHARMACEUTICALS INC
28 Feb 20
4
ENANTA PHARMACEUTICALS INC
1 Mar 19
4
ENANTA PHARMACEUTICALS INC
5 Mar 18
4
ENANTA PHARMACEUTICALS INC
21 Feb 17
4
ENANTA PHARMACEUTICALS INC
17 Feb 16
4
ENANTA PHARMACEUTICALS INC
12 Feb 16
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 Mar 23 | ENTA Enanta Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 14 | 5,800 | 81.20 k | 21,095 |
| 16 Mar 23 | ENTA Enanta Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | No | 14 | 5,800 | 81.20 k | 0 |
| 2 Mar 23 | ENTA Enanta Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 47.72 | 10,800 | 515.38 k | 10,800 |